These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy. Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164 [TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503 [TBL] [Abstract][Full Text] [Related]
5. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104 [TBL] [Abstract][Full Text] [Related]
6. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067 [TBL] [Abstract][Full Text] [Related]
7. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437 [TBL] [Abstract][Full Text] [Related]
8. Challenges in defining radiation pneumonitis in patients with lung cancer. Kocak Z; Evans ES; Zhou SM; Miller KL; Folz RJ; Shafman TD; Marks LB Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):635-8. PubMed ID: 15936538 [TBL] [Abstract][Full Text] [Related]
9. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Salem R; Parikh P; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Ibrahim S; Mulcahy MF; Kulik L; Liu DM; Riaz A; Omary RA; Kennedy AS Am J Clin Oncol; 2008 Oct; 31(5):431-8. PubMed ID: 18838878 [TBL] [Abstract][Full Text] [Related]
10. [Clinical study of radiation pneumonitis over 10 years]. Watanabe H; Suga A; Tsuchihashi Y; Hori A; Kawakami K; Masaki H; Akiyama M; Ohishi K; Takahashi A; Nagatake T Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):384-8. PubMed ID: 7791266 [TBL] [Abstract][Full Text] [Related]
11. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome. Pemberton LS; Din OS; Fisher PM; Hatton MQ Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Liu Y; Yu H; Zhang C; Cheng Y; Hu L; Meng X; Zhao Y Eur J Cancer; 2008 Nov; 44(16):2425-32. PubMed ID: 18789680 [TBL] [Abstract][Full Text] [Related]
13. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Kyas I; Hof H; Debus J; Schlegel W; Karger CP Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):768-74. PubMed ID: 17097829 [TBL] [Abstract][Full Text] [Related]
14. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy. Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421 [TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517 [TBL] [Abstract][Full Text] [Related]
17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
18. Induction therapy of loco-regional non-small-cell lung cancer with reliable response and low toxicity (low dose radiotherapy sensitizes tumor to subsequent chemotherapy?). Takita H; Shin KH; Soh AY; Yi WS; Wilding G Lung Cancer; 2009 Mar; 63(3):387-92. PubMed ID: 18676056 [TBL] [Abstract][Full Text] [Related]
19. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197 [TBL] [Abstract][Full Text] [Related]
20. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]